OVID stock · WST stock

OVID vs WST · rev $733.0K vs P/E 35, rev $1.72B

Ovid Therapeutics Inc (OVID) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.

Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.

West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.

Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.

Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.

OVID currently screens at market cap $23.5M. WST currently screens at market cap $15.97B and trailing P/E 34.8.

Not investment advice. Open the OVID and WST stock pages for the full models.

Not investment advice.

Popular Stock Comparisons